Home › Funds › Prudential Financial › VRTX

Prudential Financial position in VRTX

VERTEX PHARMACEUTICALS INCORPORATED · Health Care

Latest position (Q2 2026)133.29K sh
Reported value held$66.21M
Portfolio Weight0.07%
First reportedQ3 2021
Last changeAdd

Quarter by quarter

QuarterSharesValueChange
Q3 2021 610.78K $114.08M New
Q4 2021 660.50K $144.83M Add
Q1 2022 748.86K $195.43M Add
Q2 2022 705.63K $198.81M Reduce
Q3 2022 718.92K $208.22M Add
Q4 2022 680.49K $196.51M Reduce
Q1 2023 533.85K $168.20M Reduce
Q2 2023 474.45K $166.96M Reduce
Q3 2023 303.94K $105.90M Reduce
Q4 2023 250.82K $99.63M Reduce
Q1 2024 255.46K $106.79M Add
Q2 2024 289.64K $135.76M Add
Q3 2024 210.23K $97.78M Reduce
Q4 2024 168.14K $67.71M Reduce
Q1 2025 168.85K $81.86M Hold
Q2 2025 180.24K $80.24M Add
Q3 2025 225.81K $88.44M Add
Q4 2025 134.62K $61.03M Reduce
Q1 2026 131.56K $58.75M Reduce
Q2 2026 133.29K $66.21M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding VRTX

All VRTX fund holders →